Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
ConclusionsWe confirmed the clinical and MRI efficacy of alemtuzumab in the clinical setting and the frequency of infusion-related reactions. Compared with that in clinical trials, higher number of patients developed pneumonitis during infusion.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Brain | Clinical Trials | Disability | MRI Scan | Multiple Sclerosis | Neurology | Thrombocytopenia | Thyroiditis | Women